Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03875105
Other study ID # 2018/24-13
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date September 2, 2023
Est. completion date November 5, 2024

Study information

Verified date August 2023
Source Istanbul University
Contact Goksen Kuran Aslan, Assoc.Prof
Phone +90 (212) 414 15 28
Email goksenkuran@yahoo.com
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Lipid Storage Diseases (LSD) is a group of metabolic diseases that are manifested by exercise intolerance or muscle weakness, sometimes accompanied by systemic findings, which develop in some stages of muscle contraction due to necessary lipid transfer or destruction pathways. Exercise intolerance in LSD can limit not only physical activity but also daily activities. In the literature, no study evaluated the activities of daily living in patients with LSD. The aim of this study was to investigate the effect of exercise capacity and daily living activities on the clinical features of LSD patients.


Description:

Pulmonary functions are affected negatively in Lipid Storage Diseases (LSD). It was shown that respiratory muscle strength and peak cough flow decreased in these cases. Other respiratory system problems can be listed as; diaphragmatic dysfunction, hypoxemia, and hypercapnia. Routine evaluation of respiratory function in LSD is recommended. A limited number of studies have shown that exercise tolerance is limited by the blockage of fat oxidation on the basis of muscle weakness and fatigue in LSD. Although the assessment of exercise capacity is also an important indicator of heart-lung capacity monitoring, exercise capacity is not routinely measured in patients with LSD. Exercise intolerance can limit not only physical activity but also daily activities. In the literature, the investigator's did not find any study evaluating the activities of daily living in patients with LSD. The aim of this study was to investigate the effect of exercise capacity and daily living activities on the clinical features of LSD patients.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 25
Est. completion date November 5, 2024
Est. primary completion date September 4, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - Being diagnosed with Lipid storage disease clinically and histopathologically. Exclusion Criteria: - Severe pulmonary parenchymal disease, - Cardiac problems - Renal or hepatic dysfunction - Uncontrolled hypothyroidism - Acute infection - Malignancy

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Turkey Istanbul University Istanbul

Sponsors (2)

Lead Sponsor Collaborator
Istanbul University Biruni University

Country where clinical trial is conducted

Turkey, 

References & Publications (1)

Bingol Z, Tekce HD, Sagcan G, Serdaroglu P, Kiyan E. Pulmonary functions and sleep-related breathing disorders in lipid storage disease. Sleep Breath. 2018 Dec;22(4):1137-1142. doi: 10.1007/s11325-018-1647-1. Epub 2018 Mar 1. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary 6 minutes walking test Exercise capacity will be evaluated with 6 minutes walking test 1 day
Secondary Activity limitation (ACTIVLIM) questionnaire Activities of daily living will be evaluated Activlim questionnaire. The questionnaire is consists of 22 questions. Minimum score is 0 and total score is 88. Higher scores indicate worse conditions. 1 day
Secondary Rivermead mobility index Mobility will be evaluated with Rivermead mobility index. The questionnaire consists of 14 questions. Minimum score is 0, maximum score is 15. Higher scores indicate better conditions. 1 day
Secondary Hand held dinamometer Hand held dinamometer will be used for the measurement of upper and lower muscle strength. 1 day